دورية أكاديمية
Early detection of Ebola virus proteins in peripheral blood mononuclear cells from infected mice.
| العنوان: | Early detection of Ebola virus proteins in peripheral blood mononuclear cells from infected mice. |
|---|---|
| المؤلفون: | Ward MD; 1Systems and Stuctural Biology Division, Protein Sciences Branch, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD USA., Kenny T; 1Systems and Stuctural Biology Division, Protein Sciences Branch, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD USA., Bruggeman E; 1Systems and Stuctural Biology Division, Protein Sciences Branch, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD USA., Kane CD; 2Therapeutic Development Center, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD USA., Morrell CL; 1Systems and Stuctural Biology Division, Protein Sciences Branch, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD USA., Kane MM; 2Therapeutic Development Center, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD USA., Bixler S; 2Therapeutic Development Center, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD USA., Grady SL; 3Applied Biological Sciences, The Johns Hopkins University Applied Physics Laboratory, 11100 Johns Hopkins Road, Laurel, MD USA., Quizon RS; 3Applied Biological Sciences, The Johns Hopkins University Applied Physics Laboratory, 11100 Johns Hopkins Road, Laurel, MD USA., Astatke M; 3Applied Biological Sciences, The Johns Hopkins University Applied Physics Laboratory, 11100 Johns Hopkins Road, Laurel, MD USA., Cazares LH; 1Systems and Stuctural Biology Division, Protein Sciences Branch, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD USA.; 2Therapeutic Development Center, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD USA. |
| المصدر: | Clinical proteomics [Clin Proteomics] 2020 Mar 17; Vol. 17, pp. 11. Date of Electronic Publication: 2020 Mar 17 (Print Publication: 2020). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: BioMed Central Country of Publication: England NLM ID: 101184586 Publication Model: eCollection Cited Medium: Print ISSN: 1542-6416 (Print) Linking ISSN: 15426416 NLM ISO Abbreviation: Clin Proteomics Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Publication: 2011- : London : BioMed Central Original Publication: Totowa, NJ : Humana Press, c2004- |
| مستخلص: | Background: Detection of viral ribo-nucleic acid (RNA) via real-time polymerase chain reaction (RT-PCR) is the gold standard for the detection of Ebola virus (EBOV) during acute infection. However, the earliest window for viral RNA detection in blood samples is 48-72 h post-onset of symptoms. Therefore, efforts to develop additional orthogonal assays using complementary immunological and serological technologies are still needed to provide simplified methodology for field diagnostics. Furthermore, unlike RT-PCR tests, immunoassays that target viral proteins and/or early host responses are less susceptible to sequence erosion due to viral genetic drift. Although virus is shed into the bloodstream from infected cells, the wide dynamic range of proteins in blood plasma makes this a difficult sample matrix for the detection of low-abundant viral proteins. We hypothesized that the isolation of peripheral blood mononuclear cells (PBMCs), which are the first cellular targets of the Ebola virus (EBOV), may provide an enriched source of viral proteins. Methods: A mouse infection model that employs a mouse-adapted EBOV (MaEBOV) was chosen as a proof-of-principal experimental paradigm to determine if viral proteins present in PBMCs can help diagnose EBOV infection pre-symptomatically. We employed a liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) platform to provide both high sensitivity and specificity for the detection and relative quantitation of viral proteins in PBMCs collected during MaEBOV infection. Blood samples pooled from animals at the post-infection time-points were used to determine the viral load by RT-PCR and purify PBMCs. Results: Using quantitative LC-MS/MS, we detected two EBOV proteins (vp40 and nucleoprotein) in samples collected on Day 2 post-infection, which was also the first day of detectable viremia via RT-PCR. These results were confirmed via western blot which was performed on identical PBMC lysates from each post-infection time point. Conclusions: While mass spectrometry is not currently amenable to field diagnostics, these results suggest that viral protein enrichment in PBMCs in tandem with highly sensitive immunoassays platforms, could lead to the development of a rapid, high-throughput diagnostic platform for pre-symptomatic detection of EBOV infection. Competing Interests: Competing interestsOpinions, interpretations, conclusions and recommendations are those of the authors and not necessarily endorsed by the U.S. Army. The authors declare that they have no competing interests (© The Author(s) 2020.) |
| References: | Cytometry. 1998 Jan 1;31(1):45-52. (PMID: 9450524) Virology. 1985 Nov;147(1):169-76. (PMID: 4060597) Virology. 1998 May 25;245(1):110-9. (PMID: 9614872) Clin Microbiol Rev. 2016 Oct;29(4):773-93. (PMID: 27413095) Crit Rev Microbiol. 2017 Nov;43(6):779-798. (PMID: 28440096) BMC Immunol. 2015 Aug 26;16:48. (PMID: 26307036) J Comp Pathol. 2001 Nov;125(4):233-42. (PMID: 11798240) Lancet Infect Dis. 2016 Mar;16(3):294-5. (PMID: 26973309) J Infect Dis. 1999 Feb;179 Suppl 1:S164-9. (PMID: 9988180) Ann Saudi Med. 2014 Sep-Oct;34(5):401-6. (PMID: 25827697) J Virol. 2006 Nov;80(21):10407-18. (PMID: 16956949) J Infect Dis. 1998 Sep;178(3):651-61. (PMID: 9728532) Am J Pathol. 2003 Dec;163(6):2347-70. (PMID: 14633608) Int J Exp Pathol. 1995 Aug;76(4):227-36. (PMID: 7547435) J Infect Dis. 1999 Feb;179 Suppl 1:S199-202. (PMID: 9988185) J Proteome Res. 2013 Aug 2;12(8):3809-12. (PMID: 23692318) Science. 2014 Sep 12;345(6202):1369-72. (PMID: 25214632) Methods Mol Biol. 2017;1628:341-352. (PMID: 28573633) Virology. 2003 Aug 1;312(2):415-24. (PMID: 12919746) Viruses. 2012 Sep;4(9):1477-508. (PMID: 23170168) Nat Med. 2014 Dec;20(12):1356-7. (PMID: 25473905) J Virol Methods. 2013 Nov;193(2):291-4. (PMID: 23806566) J Infect Dis. 1999 Feb;179 Suppl 1:S28-35. (PMID: 9988162) J Virol. 2004 Jul;78(14):7344-51. (PMID: 15220407) J Mol Biol. 2016 Aug 28;428(17):3449-66. (PMID: 27189922) J Infect Dis. 1999 Feb;179 Suppl 1:S248-58. (PMID: 9988191) J Infect Dis. 2016 Oct 15;214(suppl 3):S210-S217. (PMID: 27587634) J Infect Dis. 1999 Feb;179 Suppl 1:S177-87. (PMID: 9988182) Lancet. 2015 Aug 29;386(9996):867-74. (PMID: 26119838) Chembiochem. 2006 Oct;7(10):1605-11. (PMID: 16977667) J Infect Dis. 2016 Oct 15;214(suppl 3):S203-S209. (PMID: 27521365) J Virol Methods. 2000 Mar;85(1-2):175-82. (PMID: 10716350) J Infect Dis. 2016 Oct 15;214(suppl 3):S145-S152. (PMID: 27365495) J Infect Dis. 2007 Nov 15;196 Suppl 2:S296-304. (PMID: 17940964) Clin Chem. 2013 Oct;59(10):1470-80. (PMID: 24014836) J Clin Virol. 2016 Apr;77:9-14. (PMID: 26874083) Acta Pathol Jpn. 1990 Feb;40(2):107-15. (PMID: 2140233) |
| فهرسة مساهمة: | Keywords: Diagnostics; Ebola virus; Mouse adapted Ebola virus; Quantitative proteomics |
| تواريخ الأحداث: | Date Created: 20200321 Latest Revision: 20220413 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC7077124 |
| DOI: | 10.1186/s12014-020-09273-y |
| PMID: | 32194356 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1542-6416 |
|---|---|
| DOI: | 10.1186/s12014-020-09273-y |